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Abstract. The mouse progenitor T lymphocyte (proT)
cell line FTF1 binds in vitro to thymus blood vessels,
the thymic capsule, and liver from newborn mice. A
mAb, EA1, raised against an embryonic mouse endo-
thelial cell line, blocked adhesion. The antibody also
interfered with proT cell adhesion to a thymus-derived
mouse endothelial cell line; it had no effect on the ad-
hesion of mature T lymphocytes and myeloid cells.
The antigen recognized by EA1 is located on the vas-
OLONIZATION ofthe mouse thymus by T lymphocyte
progenitors from fetal liver occurs apparently in a
wave starting at day 10 of embryonic development
(Moore and Owen, 1967; Saladn et al., 1986; Jotereau et al .,
1987; Savagner et al ., 1988; Palacios and Samaridis, 1991) .
In postnatal life, T cell progenitors (proT cells)' from the
bone marrow continually migrate into the thymus, albeit in
smaller number, and,there they develop into the various thy-
mocyte populations (Scollay et al., 1986; Kyewski, 1987;
Adkins et al., 1987; Savagner et al., 1988; Deugnier et al.,
1989; Palacios et al., 1990). proT cells, the earliestdifferen-
tiation stage in the T-lymphocyte lineages (Palacios and Pel-
konen, 1988), are transported to the thymus via the blood
circulation (Savagner et al., 1986; Dunon et al., 1990; Pala-
cios et al., 1990) . A critical first step in the process of thy-
mus colonization is the adhesion of proT cells to the peri-
thymic vascular endothelium.
Adhesion of mature hemopoietic cellsto endothelium has
been extensively studied (Harlan, 1985; Rosen, 1989; Stool-
man, 1989; Osbor,, 1990; Springer, 1990a; Albelda and
Buck, 1990). Several classes of adhesion molecules present
on endothelium participate in this process. ELAM-1 and
PADGEM/GMP140 constitute the so called selectin fam-
ily or LECAM (Bevilacqua et al., 1989 ; Johnston et al.,
1989). ICAM4, ICAM-2, PECAM-1/EndoCAM, and VCAM
belong to the group designated as cell adhesion molecules
(CAM) and more widely to the Ig structure superfamily
(Simmons et al., 1988; Horley et al ., 1989; Staunton et 0 .,
1989; Albelda et al., 1990; Newman et al., 1990; Elices et
1. Abbreviations used in this paper: CAM, cell adhesion molecule; DPBS,
Dulbecco's PB; HEV, high endothelial venules; IMDM, Iscoves modified
MEM; proT cells, T cell progenitors.
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cular endothelium of various mouse tissues and absent
on proT cells. EA1 antibody precipitates molecules
with apparent molecular weights of 110,000, 140,000,
160,000, and 200,000. Immunoclearing and binding-
inhibition studies with antibodies against known adhe-
sion molecules suggest that the EA-1 antigen is a novel
adhesion molecule involved in colonization of the em-
bryonic thymus by T cell progenitors.
al., 1990). Most of these molecules can be induced to be ex-
pressed on certain endothelia by tissue inflammation in vivo
or by cytokine treatment in vitro (Osbom, 1990). Finally the
integrins, consisting ofan ci and a ß subunit, are widely dis-
tributed on different tissues and participate in both, cell-cell
and cell-substrate interaction (Albelda and Buck, 1990). All
these molecules seem to be involved in homing of various
hemopoietic cell lineages to a variety of tissues. A more re-
stricted tissue or organ-specific homing has been foundin the
lymphoid system (Streeter et al., 19ß8a; Springer, 1990b) .
Thus, lymph nodes and Peyer's patches contain specialized
blood vessels with a characteristic morphology, the high en-
dothelial venules (HEV), to which mature lymphocytes bind.
mAbs, directed against HEV antigens, blocklymphocyte ad-
hesion on HEV in the mucosaand others in peripherallymph
nodes (Streeter et al., 19ß8b; Nakache et al., 1989). Because
such endothelial adhesion molecules are expressed in spe-
cific organs and because they seem to determine where cir-
culating mature lymphocytes will exit the bloodstream, they
are referred to as addressins (Berg et al., 1989).
Little is known about the interaction of lymphocyte pro-
genitors with endothelium during development. Moreover,
little is knownaboutthe existence ofadhesion molecules that
participate in the homing of lymphocyte progenitors to par-
ticular tissues or organs (Tavassoli and Hardy, 1990). We
generated a mAb, EA-1, that reacts with a protein expressed
on mouse endothelial cells. It inhibits the binding of proT
cells to thymic endothelium, but it has no effect on adhesion
of mature T lymphocytes or myeloid cells to tissues. Thus
we provide evidence for restrictedbinding of T-cellprogeni-
tors to thymic endothelium, and we have identified on the
surface of endothelial cells, a novel protein involved in that
process.The Journal of Cell Biology, Volume 114, 1991
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Figure 1. Binding of FTFI pro-T cells to frozen sections of tissue
from newborn mice . (A) Photograph of frozen sections from the
binding assay. FTFI appear as large round cells with ashiny surface
easily distinguishable from the frozen sections (see arrows). (a)
Cortico-medullary junction of thymus ; FTFI cells bound to a
blood vessel . (b) Cortical region andcapsule of the thymus ; FTFI
cells bound to the capsule. (c) Liver; (d) kidney ; (e) lung; (f)
heart. The inset ina shows medulla and cortex of a newborn thy-
mus . The arrowhead points to FTFI cells bound to a blood vessel .
(B) Quantitation of bound cells permicroscope field . Mean values
represent five independent assays with a total of20 counted micro-
scope fields per assay. Bar, 100 gym .Table I.
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In A the symbols are as follows: -, <3 cells/field; +, 3-15 cells/field; ++,
16-40 cells/field. In B the symbols are as follows: -, 0%; +, 1-30%; ++,
31-60% ; +++, 61-100%.
The development, characterization, and functional potential of the pro-T
cell clone FTFI are described elsewhere (Pelkonen et al., 1987; Palacios
et al., 1989). They were grown in culture medium in the presence ofInter-
leukin 2 as described (Palacios et al., 1989). For further binding studies
we used the pre-B cell lymphoma 18-81 (Alt et al., 1981), early pre-B cell
lymphoma 40E1 (Alt et al., 1981), the mature B cell line L10A62 (Kim et
al., 1979) and the carcinoma cell line KLN 205 (American Type Culture
Collection, Rockville, MD). Endothelialcells, eEnd.2 (derived frommouse
embryo) and tEnd.l (derived from young mouse thymus), obtained from
E. Wagner, Institute for Molecular Pathology (Vienna), are both endo-
thelioma celllines transformed by thepolyoma middle Toncogeneand cul-
tured as described (Williams et al., 1989).
FITC (Sigma Chemical Co., St. Louis, MO) was prepared as a 25.7 mM
stock solution in DMSO (Fluka AG, Buchs, Switzerland) and processed as
described (Imhofet al., 1990). Briefly, 100 Kl stock solution was added to
Figure 2. Inhibition of proT cell binding on frozen sections of new-
bom thymus and liver by EA-1 antibody. FTFI cells were mixed
with SP 2/0 supernatant(control) or with EA-1 hybridoma superna-
tant (EA1) and used in the binding assay. Control rat antibodies of
the same isotype as EA-1 gave identical results as the SP 2/0 control
(not shown).
Figure 3 Binding of pro-T cells and peripheral mature T lympho-
cytes on thymus-derived endothelial cell line, tEnd.l. FTFI and T
cells were first FITC labeled and then used for binding on endothe-
lial cells plated in microtiter plates. Bound cells were counted by
measuring fluorescenceon a Fluoroskan II microtiter reader. ProT
cell binding was inhibited by antibody EA1; binding ofmature pe-
ripheral T cells was not. A mean of 5.5 x 103 f 0.5 x 103 FTFI
cells and 3.3 x 103 t 0.25 x 103 peripheral T cells (both taken
as binding index 1) bound to a monolayer containing 3 x 10^
t.End.l cells per well. Three independent experiments were taken
with 10 wells per value.
a 1 ml cell suspension containing between 0.5 and 4 x 107 cells in DME
(Gibco BRL, Paisley, UK) and incubated at 4°C for 15 min in the dark.
Labeled cells were then centrifuged through a layer of 5 ml 10% BSA for
15 min at 460 g at room temperature. Cells were washed with DME, and
cell viability was assessed by the trypan blue dye exclusion test.
Cell AdhesionAssays
On Frozen Sections. In situ binding was performed on freshly prepared fro-
zen sections from neonatal mouse tissue (Woodruff et al., 1987). Organs
were embedded and frozen inTissue Tek, O.C.T. Compound (MilesLabora-
tories Inc., Elkhart, IN), sectioned to 5 AM thickness, and mounted onto
glass slides. The sections were outlined by a PapPen (SCIScience Services,
Munich, Germany) and immediately placed into Dulbeccds PBS (DPBS)
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Figure 4. Analysis of surface staining by antibody EA-1 on two en-
dothelial cell lines (eEnd.2 and tEnd.1) and on the pro-T cell line
(FTFI). Adherent cells were rapidly detached by trypsin and stained
in suspension; the fluorescence detected on a FACScan. Cell num-
ber is plotted on the linear scale, fluorescence is plotted on a loga-
rithmic scale.
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1072containing I% BSA for at least 10 min. Slides weredriedaround the Pappen
marked area and the tissue section then loaded with 105 pro-T, lymphoma
or carcinoma cells in 200 Al DPBS. Binding was allowed to occur for 40
minat 8°C on a mini-shaker(A. KiihnerAG, Basel, Switzerland) at 50rpm.
Slides were then placed vertically into DPBS containing 0.5% glutaralde-
hyde and2 % formaldehyde, where nonbound cells were allowed to fall off.
After 20 minoffixationat roomtemperature, proT cells bound to the tissue
section under study were counted using a light microscope (Axiophot;
Zeiss, Oberkochen, Germany).
On Cultured Cells. Endothelial cells were seeded into 96-well (no.
3596; Costar Data Packaging, Cambridge, MA) microtiter plates (3 x 104
cells/well) and cultured for 24 hr. After removing the medium, FITC-
labeled proT cells, peripheral T cells, or polymorphonuclear leukocytes
were added (105 cells/2001c1/well) and incubated at 20°C for 2 h. Unbound
cells were removed by washing three times with DPBS containing 1% BSA;
the plates were "flicked" dry between washes. Fluorescence, corresponding
to cells bound in DPBS, was measured by a Fluoroskan II reader flitertek,
Elfab Oy, Finland) (Imhofet al., 1990). The bindingindex is defined as the
ratio ofthe number ofcells bound to endothelium in thepresence of block-
ing antibody to the number of cells bound in control medium.
Pblymorphonuclear Leukocytes, Peripheral
TLymphocytes, and BloodPlatelets
For the isolation of leukocytes, we followed the protocol described by
Lewinsohnet al. (1987). Briefly, blood was centrifuged onto a Percoll cush-
ion (83.6% Percoll, 1.6% H20, 14.8% lOx HBSS, and 5 mM EDTA).
Cells from the interface were collected, stained with May-Grüpwald=
Giemsa, and used for binding assays.
Peripheral T lymphocytes were obtained from mouse spleens by a nega-
tive sorting procedure. Briefly, to remove macrophages and B lymphocytes,
spleen cells were incubated for 30 min with antibodies specific for macro-
phages (Mac-1) and B cells (B-220) followed by sheep anti-mouse IgG
coated Dynabeads (40 beads/1 cell; Dynal A.S., Oslo, Norway). Bound
cells were separated with the MACS magnet (Biotechnische Geräte, Glad-
bach, Germany).
Blood platelets were prepared by differential centrifugation as described
(Catalfamo and Dodds, 1989).
Antibodies
Rabbit anti factor VIIIserum waspurchased from Behringwerke (Marburg,
Germany). Antibody H 154.163 (anti-LFA-1) was kindly provided by Dr.
P Naquet (Centre d1nmunologie de Marseille Luminy, Marseille, France),
YNl/1.7 (and-ICAM-1) by Dr. F Tàkei (Karolinska Hospital, Stockholm,
Sweden). 142/5 (anti CD44) from Dr. I. S. Trowbridge (The SalkInstitute,
San Diego, CA), andpolyclonal anti-EndoCAM by Dr. C. Buck (TheWistar
Institute, Philadelphia). Antibody Mel 14 was obtained from ATCC. Secon-
dary antibodies were RITC-labeled goat anti-rabbit IgG (Cappel Labora-
tories, Cochranville, PA), FITC-labeled goat anti-rat IgG (Jackson Immuno
Research Laboratories Inc., Avondale, PA), FITC-labeled anti-rat IgG28,
and Biotin anti-rat IgG2b (both from The Binding Site LTD, Birmingham,
UK). Biotin-labeled streptavidin was from Amersham International (Amers-
ham, UK).
The rat mAb EA1, a IgG2 was prepared according to an immunization
and cell fusion protocol described by Dr. M. Kosco (manuscript in prepara-
tion). Confluent endothelial cells (eEnd.2) from a 150 cm2 culture flask
were irradiated with 10,000 rod and harvested with cell scrapers (Costar
Data Packaging). These cells were then washed with DPBS, mixed 1:1 with
complete Freund's adjuvant for a final volume of 30011, and injected sub-
cutaneously into the dorsal surface of the hind foot of a 2-mo-old PVG rat.
Injections with cells in DPBS only were repeated after 7 and 14 d. At day
17, the drainingpopliteal lymph node was dissected from the rat. The tissue
was enzymatically digestedusing the following enzymestock solutions: 150
mg/ml protease type IX (P-6141; Sigma Chemical Co.); 8 mg/ml col-
lagenase CLS 4 (Worthington Biochemical Corp., Freehold, NJ); 10 mg/ml
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DNAse I (D-0876; Sigma Chemical Co.). The enzyme solutions were
mixed to a final volume of 2 ml (0.5 ml Collagenase, 0.1 ml Protease, 0.1
ml DNAse, 1.3 ml IMDM [Iscoves modified MEM; Gibco BRL]). A lymph
node was opened by two slight crosscuts using a 25-gauge needle. Stroma
were then digested at 37°C for two 30-min periods each with 1 ml enzyme
cocktail. The cells were then carefully released into IMDM with Pasteur
pipettes, washed in 50 ml IMDM, and counted. One part lymph node cells
was then mixed with five parts mouse Sp2/0 myeloma cells, centrifuged,
and fused with PEG4,000 (E. Merck, Darmstadt, Germany) as described
in Harlow and Lane (1988). The cells were thenplated (100 Al) into condi-
tioned medium in microtiter plates (96 wells; Costar Data Packaging) at a
density of 5 x 104 cells/well in IMDM selection medium containing HAT
(Gibco BRL), 10% FCS (Boehringer Mannheim GmbH, Mannheim, Ger-
many), 50 AM 0-mercaptoethanol, penicillin/streptomycin, and glutamine.
Conditioned medium was produced by culturing 104 PVG rat thymocytes
(10011/well) in selection medium for three days before fusion. The IgG was
purified from hybridoma supernatant on protein G affinity columns (Phar-
macia Fine Chemicals, Uppsala, Sweden).
Immuno,fluorescence
Frozen sections werefixed with acetone and labeled with supernatant ofthe
EA-I hybridoma raised against eEnd.2 cells, followed by an FITC-
conjugated goat anti-rat IgG antibody (Jackson Immuno Research Labora-
tories Inc.). To evaluate staining of adherent endothelial cells by flow
fluorocytometry analysis (FACScan; FACs is a registered trademark ofBec-
ton Dickinson and Company, Mountain View, CA), the cells were first re-
moved from the culture flasks by a very rapid trypsin treatment which does
not affect EA-1 antigen. Addition of completemedium stopped thereaction.
The cells in suspension were stained by unlabeled EA1 followed by the
same FITC-conjugated goat anti-rat IgG described above.
Immunoprecipitation
To determine the molecular weight of the protein recognized by EA-1,
confluent endothelial cells grown in a 150-cm2, culture flask were surface
iodinated by the lactoperoxidase/glucoseoxidase method described else-
where (Marchalonis, 1969). Briefly, cells were washed twice with DPBS
and incubated with 1.5 mCi 125Iodine, 2 ml DPBS containing 1 U/ml lac-
toperoxidase, 2 U/ml Glucoseoxidase, and 0.2% 0-i>-glucose. After 30-min
incubation at room temperature, the cells were washed eight times with
complete medium. Radioactive cells in DPBS containing 2 mM PMSF
(Sigma Chemical Co.) and 1 TIU/ml Aprotinin (Sigma Chemical Co.) were
harvested from the flask with a cell scraper (Costar Data Packaging). The
cells were suspended in lysis buffer (2% NP-40 [FlukaAG], 150 mM NaCl,
50 mM Tris, pH 8, 2 mM PMSF, and 1 TIU/ml Aprotinin) and centrifuged
for 10 min at 10,000 g. The supernatantwas cleared twice with 100 141 San-
sorbin (Calbiochem-Behring Corp., San Diego, CA) and a rabbit anti-rat
serum (Jackson Laboratory, Bar Harbor, ME) for 30 min each. Hybridoma
supernatant and a rabbit anti-rat serum (1:20) was added to an aliquot of
the cleared lysate and precipitation was performed using 3014 Pansorbin
(Calbiochem-Behring Corp.). Pellets were washed three times with lysis
buffer, boiled in SDS-dissociation buffer, and run on SDS-PAGE, 5-15%
acrylamide.
Results
PTFIpro-TCellsBindto Thymic TYssue
The FTF1 cell line has cellular, molecular, and functional
properties of proT cells, the progenitors that are the earliest
stage of T cell development (Pelkonen et al., 1987; Palacios
et al., 1989). FTFl cells express the proT cell specific sur-
Figure S. Immunofluorescence labeling of EA-I on various mouse tissues. Frozen sections of neonatal or adult mouse tissue were used
for staining. (A and B) Double staining using EA-I followed by labeled (Texas red) anti-rat IgG and rabbit anti-factor VIII followed by
FITC labeled anti-rabbit IgG. (A) Cortical region of the thymus stained for EA-1. (B) Double staining for endothelial marker factor VIII.
(C) EA-1 staining ofthe thymic cortico-medullaryjunction, apical surface, and cell-cell contactofendothelial cells are stained. (D) Corre-
sponding phase contrast image, note endothelial adherent hemopoietic cells in the large capillary. (E) EA-1 staining of neonatal liver; the
capillaries are positive. (F) EA-I staining of adult spleen, all endothelia are positive. (G) Adult mouse blood platelets stained for EA-1.
(H) Corresponding interference contrast image. Bars: (A-F) 100 um; (H) 10 Am.Figure 6. Double staining of adult bone marrow cells using EA-1
and typing antibodies forhemopoietic lineages . Total bone marrow
cells were either single (EA-1, thy-1, B220, or Mac-1) or double
stained (EA-l+thy-1, EA-1+B220,EA1+Mac-1) . EAl labeling was
detected by a FITC-coupled anti-IgG2, antibody and the hemo-
poietic markers by Biotin-coupled anti-IgG2n antibody followed by
phycoerythrin coupled avidin . Subpopulations ofimmature T and B
lineage cells and immature myeloid cells were EA-1 positive . (a)
Percent ofcells in foreward vs side scatter, FACS window RI corre-
sponds to mature lymphocytes, FACSwindow R2 to immature cells .
face markers, Joro 75 and Joro 37-5 ; progenitor cells bearing
these markers have been shown to migrate into and colonize
the thymus both in the developing embryo and in adult mice
(Palacios et al ., 1990 ; Palacios and Samaridis, 1991) . There-
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fore, we thought that the behavior of FTFI proT cells in
functional thymus homing assays invitro would be a measure
of interactions between proT cells and thymic tissue in vivo
(Stamper and Woodruff, 1976) .
We find that FTFI cells bind to frozen sections of
thymuses from newborn mice. They are concentrated on the
thymic capillaries and especially to the larger blood vessels
of the thymic cortico-medullary junction (Fig . 1 A) . They
also adhere to areas in the outer cortex and in the capsule
of the isolated thymus, but less frequently. The FTF1 pro-T
cells also bind to frozen sections of liver from newborn
mouse, but they did not adhere to kidney, lung, or heart tis-
sues . Twice as many FTFI cells adhered to the thymus than
to the liver (Fig . 1 B and Table IA) . Thus, in contrastto other
cell lines tested, as wouldbe expected of a proT cell, FTF1
shows a clear preference for adhering to hemopoietic organs .
mAbEA1 InhibitsproT CellAdhesion
to Thymic Endothelium
In an attempt to identify adhesion molecules involved in
homing to the thymus, we prepared ratmAbs against the en-
dothelial cell line eEnd.2 (derived from mouse embryonic
tissue ; Williams et al ., 1989) and tested them in the frozen
section binding assay. The antibodyEA1 totally blocked the
binding of FTFI, partially a carcinoma but not the other he-
mopoietic cell lines to neonatal thymus (Fig . 2 and Table I
B) . The limitedbinding ofFTFIproT cells to neonatal liver
was only partially blocked . Thus the antigen recognized by
EA1 antibody seems to be more important for the adhesion
of proT cells to thymic tissue than it is for their adhesion
to liver.
To study binding to endothelia in vitro, we have developed
an automated assay which involved culturing FTFI pro-T
cells labeled with fluorescenn isothiocyanate on a layer ofthe
thymus derived endothelial cell line tEnd .l (Williams et al .,
1989 ; Imhofet al ., 1990) . A microtiter reader equipped with
a fluorimeter was used to count fluorescent cells adhering to
this monolayer. The antibody, EA-1, inhibited binding of
FTF1 cells to tEnd .l endothelia in control medium by 60%
(Fig . 3) . EA1 did not affect the binding of mature peripheral
T cells to the thymic endothelial cell line (Fig . 3), nor did
it affect the adhesion ofpolymorphonuclear leukocytes (data
not shown) .
Using FACS (Becton Dickinson and Co .) analysis we es-
tablished thatEA1 recognized a cell surface antigen on en-
dothelial cell lines of either embryonic (eEnd.2) or thymic
(tEnd.l) origin . FTFI proT cells did not bind EA-1 (Fig . 4) .
ICAM Mel14
1074
Figure 7 . Regulation of theexpression of
adhesion molecules on eEnd.2 endothe-
lial cells. Cells were treated with 100
U/ml IL-1 or IFN-y overnight, rapidly
detached from the culture dish, and
stained in suspension with indicated
antibodies . EA-1 and CD-44 showed
no upregulation, LFA 1, ICAM-1, and
Me114 showed increased expression af-
ter cytokine treatment .
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_ . _Figure 8. Ability of pro-T cells or polymorphonuclear leukocytes
to bind to eEnd.2 endothelia following cytokine treatment of en-
dothelium. (A) Endothelial cells were cultured over nightwith 100
U/ml IFN-.y or IL-1 and then used for binding assays with FTFI
cells. (B) Corresponding experiment using polymorphonuclear
leukocytes. The number ofbound FTFI control cells was the same
as in Fig. 3.
These findings suggest that the EA-1 antigen on endothelia
recognizes an as yet undefined molecule on proT cells.
Tissue Distribution oftheAntigen
Recognized byEA1
Using an analysis by immunofluorescence staining and mi-
croscopy of frozen sections from newborn mouse tissue we
showed that the EA1 antibody stains blood vessels in the thy-
mus. The endothelial nature ofthe cellspositive for EA1 was
demonstrated by double labeling assays with EA-1 and anti-
factor VIII antibodies as an endothelial marker (Fig. 5). The
labeling pattern of EA-1 on the luminal side of endothelial
cells was compared with that in regions of cell-cell contact.
We found that EA-1 reacts with an antigen present on all thy-
mic capillaries. However, the EA-1 antibody also bound to
vascular endothelia in newborn liver, spleen, lung, kidney,
and brain (Fig. 5; and data not shown) . In adult tissues, the
antigen recognized by EA-1 was detected on endothelia of
many tissues (as shown in Fig. 5 for spleen), on a subpopula-
tion of immature hemopoietic cells from the bone marrow
(Fig. 6) and, on freshly isolated blood platelets (Fig. 5,
G and H) .
control LFA-1 CD44 Mol-14 EA-1
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Relationship ofEA1Antigen to Other
CellAdhesionMolecules
It is known that several adhesion molecules known to be ex-
pressed on endothelial cellscan be upregulated by inflamma-
tory reactions mediated by endotoxins or cytokines. IL-1
failed to induce a higher expression of the EA-1 antigen on
the endothelial cell line eEnd.2, but INF-y had a slight effect
on a negative subpopulation (Fig. 7). Another adhesion mol-
ecule, CD44, showed no significant change. By contrast
LFA-1, ICAM-1 and gp9()Me114 were upregulated upon cyto-
kine treatment. Induction of LFA-1 and gp90MA14 expression
on eEnd.2 cells by IL-1 is a novel and interesting finding. It
may be because of the fact that this particular cell line is of
embryonic origin.
In analogy to the induction of adhesion molecules, inflam-
matory reactions increase the binding capacity of endothe-
lium for myeloid cells or mature lymphocytes (Osborn,
1990). We found that treatment of eEnd.2 endothelium with
IL-1 reduced pro-T cell binding (Fig. 8A). By contrast, poly-
morphonuclear leukocytes bound slightly better to endothe-
lia treated with IL-1 or IFN-y (Fig. 8 B).
Antibodies directed against the known adhesion mole-
cules, LFA-1, CD44, and gp90M°114 did not interfere with
proT cell adhesion to tEnd.l endothelial cells (Fig. 9 A) . In-
terestingly, antibodies against the integrin LFA-1 slightly in-
creased the inhibitory effect of EA-1 antibodies (Fig. 9 B) .
Immunoprecipitation oftheAntigen
RecognizedbyEA1
After surface iodination, endothelial cell (eEnd.2) proteins
were solubilized and immunoprecipitated with EA1. SDS-
PAGE, under reducing conditions, detected bands at a mo-
lecular weight of 110,000, 140,000, 160,000, and 200,000
(Fig. 10). Nonreducing conditions did not significantly
change the pattern. However, depending on experimental
conditions the intensity ofthe individual bands varied, prob-
ably because of limited digestion. The molecular weight of
one band (140,000) is similar to that of PECAM/endo-
CAM/CD31 which is also expressed on endothelia and plate-
lets. But using immunoclearing with a polyclonal anti-CD-
31 antiserum, we could clearly show that the two molecules
are different (Fig. 10).
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Figure 9. Adhesionmolecules involved
in inflammation do not interfere with
pro-T cell adhesion. Binding ofFTFI
cells on tEnd.l endothelia was per-
formed as described in Fig. 3. Anti-
bodies against LFA-1, CD44, and
gpgoMei-14, and the antibody EA-1,
were added as hybridoma supema-
tantsin the FTFI binding assay. Syn-
ergistic effects of the various adhe-
sionmolecules onFTFI binding were
studied by mixing the above antibod-
ies with EA1 in the adhesion assay.
Only anti-LFA1 showed a minor ef-
fect. The numberofboundFTFI con-
trol cells was the same as in Fig. 3.Figure 10 . Immunoprecipitation and immunoclearng withEA 1 an-
tibody and a polyclonal anti-CD31 antiserum . Surface 1z5Iodinated
eEnd.2 cells wereprepared for immunoprecipitation using the anti-
bodies and Staphylococcus aureus . Theprecipitate was analyzed by
a reducing SDS-PAGE followed by sutoradiography . (a) Precipita-
tion with EA-1 . (b) Precleared withanti-CD31 and precipitated with
EA-1 . (c) Precipitation with anti-CD31 . (d) Precleared with EA-1
and precipitated with anti-CD31 .
Discussion
proT CellsInteract Specifically
with Thymic Endothelium
Here we have shown that proT lymphocytes bind to thymus
and liver from newborn mice as well as to an endothelial cell
line derived from thymus . This property of T-cell progeni-
tors appears restricted to vessels in hemopoietic tissue ; that
is, they do not adhere to endothelia in other organs such as
kidney, lung, or heart . The EA-1 antibody reacts with mole-
cules of apparent molecular weights of 110,000, 140,000,
160,000, and 200,000, which are components of the plasma
membrane of endothelial cells .
Although it recognizes an antigen expressed on vascular
endothelium from several tissues, EA1 effectively blocks the
binding ofproT cells to thymus-derived endothelium, but it
does not affect the adhesion of mature T lymphocytes or my-
eloid cells to any tissue . This result strongly suggests that the
molecules recognized by the EA-1 antibody on endothelial
cells selectively participate in the adhesion ofproT cells to
thymic endothelium . EA-1, located on other tissues may ei-
ther not be functional or it could be involved in homotypic
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endothelial cell-cell contact . The specificity of EA-1 antigen
for proT cells in the thymus might result from interaction
of the endothelium with the thymus in a way that alters its
binding affinity . Such a process is also thought to be involved
in LFA1-mediated adhesion and deadhesion of lymphocytes
(Dustin and Springer, 1989 ; Figdor et al ., 1990) . Specificity
might also result from posttranslational modifications of the
antigen, as had been shown for the receptor molecule of
ELAM-1 or PADGEM/GMP-140, lacto-N-fucopentaose III
(Walz et al., 1990 ; Larsen et al., 1990 ; Lowe et al., 1990 ;
Phillips et al ., 1990) . Moreover, different adhesion mole-
cules may act together and tissue specificity is probably
created by the proportional number of these molecules to
each other (Hamann et al ., 1988) .
In addition to proT cells, peripheral mature T cells and
polymorphonuclear leukocytes adhere to the endothelial cell
lines tested here . ButEA1 antibody specifically blocked the
adhesion of FTF1 proT cells without affecting that of other
hemopoietic cell lineages. Also, IL-1, a cytokine involved in
inflammatory reactions, stimulated the binding of myeloid
cells but had a negative effect on proT cell binding . Thus,
the binding of these various hemopoietic cells seems to de-
pend on interaction with a different set of adhesion mole-
cules . Moreover, these results suggest that the homing of
proT cells to the thymus uses molecular mechanisms differ-
ent from those described for inflammation mediated cell
adhesion to endothelia .
The in vitro assay described here ought to prove valuable
in studying thymic specific homing mechanisms involved in
embryonic pattern formation .
TheEA1Antigen IsA Novel Adhesion Protein
The question arises whether the EA-1 antigen is a novel mol-
ecule or whether proT cell binding to thymic endothelium
is a function of a previously described adhesion molecule .
PADGEM/GMF-140, a protein-mediating cell adhesion of
hemopoietic cells to endothelia, has a similar tissue distribu-
tion and the same molecular weight as the EA-1 antigen
(Johnston et al ., 1989 ; Parmentier et al ., 1990) . However
several experiments reveal major differences between the
two molecules . EA-1 is mainly expressed on the cell surface,
whereas GMP-140 colocalizes with factor VIII, in Weibel-
Palade bodies in endothelial cells (Bonfanti et al ., 1989) .
Only inflammatory activation ofthe cells bringsGMP-140 to
the cell surface (Osborn, 1990) . EA-1 is constitutively ex-
pressed on endothelial cell surfaces and stimulation of these
cells by IL-1 does not increase the expression of EA-1 .
PECAM-1/EndoCAM, another adhesion molecule found on
endothelium is found on the apical plasma-membrane and
in cell-cell junctions of endothelial cells . Its published mo-
lecular weight is 130 kd (Newman et al., 1990) . Identity
with EA-1 could be excluded by immunoclearing, which was
possible because of bovine/mouse crossreactivity of a poly-
clonal anti-EndoCAM antibody (Albelda et al., 1990) . The
other adhesion molecules ELAM-1, PgPLl/CD44, I-CAM,
gpgoME.", 01, and ß4 integrins differed from EA-1 in molec-
ular weight, tissue distribution pattern, and their regulation
ofcell surface expression (Pont et al . ;, 1986 ; Simmons et al
1988 ; Picker et al., 1989 ; Zhou et al., 1989 ; Siegelman et
al ., 1989 ; Albelda and Buck, 1990 ; Hogervost et al ., 1990;
Stoolman, 1990) . Therefore, we conclude that the EA-1 anti-
gen has notbeen previously described. Our data suggest that
1076it selectively plays a role in the adhesion of T lymphocyte
progenitorcellsto endothelium. Interestingly, the EA-1 anti-
gen may also be involved in carcinoma cell adhesion to en-
dothelium. Adhesion molecules used by cellsofthe immune
system have already been found to play a role in cancer
metastasis and they may open possibilities of applications in
therapy (Rice et al., 1989; Giinthert et al., 1991) . We are
currently attemptingto isolate cDNA encoding the molecule
recognized by EA-1 antibody to further define the nature,
function, and relatedness of this protein with other adhesion
molecules.
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